Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
INTRODUCTION Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disorder caused by autoantibodies targeting type VII collagen, which is a critical component of anchoring fibrils responsible for maintaining the…
Read More